Mini-dose glucagon (MDG) is an effective approach for preventing exercise-induced hypoglycemia in patients with type 1 diabetes, according to a study published online May 18 in Diabetes Care.
Michael R. Rickels, M.D., from the University of Pennsylvania in Philadelphia, and colleagues aimed to determine whether MDG given subcutaneously pre-exercise could prevent glucose lowering and compared the glycemic response to current approaches for mitigating exercise-associated hypoglycemia.
Mini-glucs will be a great new tool for those of us who use insulin. It appears Xeris Pharamceutical is getting closer (end of quarter 2, 2018) to filing a new drug application or NDA with the FDA. I’m hoping this means access this year. I really think we will benefit from a smoother BG ride when we can take a mini-gluc injection instead of eating glucose tabs. It appears from the study cited here that mini-gluc helps with exercise hypos, too.
This will be super useful us, the nights after weekend tournaments are challenging to balance.